Drug Study Shows Promise For Alzheimer’s, Neurological Disorders

A new drug, developed by the Salk Institute for Biological Studies, may be the first to improve memory and prevent brain damage caused by Alzheimer’s disease. The compound, named J147, showed promise when tested on mice and could be tested for humans in the near future. David Schubert, head of Salk’s Cellular Neurobiology Laboratory, said J147 enhances memory in both normal and Alzheimer’s mice and protects the brain from the loss of synaptic connections. The compound’s ability to protect nerve cells may mean it could also be an effective treatment for Parkinson’s disease and other neurological disorders. The National Institutes of Health estimate that there are 5.4 million Americans with Alzheimer’s disease. More here.

This entry was posted in Healthy Living. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s